May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
Daily Dose: Electronic “Nudges” to Increase Flu Vaccination Uptake
Your daily dose of clinical news you may have missed.
Electronic “Nudges” Linking Flu Vaccination to Potential CV Benefits Boosted Uptake in Older Adults in Denmark
ACC 2023. Electronic nudges highlighting the potential cardiovascular benefits of flu vaccination led to a modest uptake in vaccination rates among older adults in Denmark, according to results of the NUDGE-FLU trial.
Immunization Levels Disheartening This Flu Season, Says William Schaffner, MD
Vaccine uptake this respiratory virus season is lagging compared to previous years, says Schaffner, medical director of the National Foundation for Infectious Diseases.
Respiratory Tripledemic 2022-23: Expert Update, Top Challenges
Distinguishing between influenza, COVID-19, and RSV and persuading vaccine-weary patients to get vaccinated are some of the challenges this season, says William Schaffner, MD.
CDC Releases First Estimates of Bivalent mRNA COVID-19 Booster Effectiveness against XBB/XBB.1.5
Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.
ACIP 2023 Vaccination Schedule Update, At-a-Glance
Among the CDC vaccine advisory group's recommendations are adding COVID-19 vaccines to the Vaccine for Children program and allowing PCV20 shots for those who previously received PCV13.
Daily Dose: Bivalent Boosters Protect Against Severe COVID-19 Disease
Daily Dose: Parent-Pediatrician Vaccine Discussions Lagging?
Parent-Pediatrician Vaccine Discussions are Lagging, National Poll Finds
One in 7 parents have not discussed vaccines with their child's primary clinician during the 2-year pandemic period, according to a CS Mott Children's Hospital poll.
Investigational Fentanyl Vaccine Could Block the Opioid from the Brain
A vaccine against fentanyl could stop the intense euphoria the drug creates and also block dangerous physiologic responses like respiratory depression, a new study suggests.
Pediatric RSV Vaccines: Why Are We Still Waiting?
I have admitted infants to the hospital every winter for 40 years, yet I still don't have good answers for anxious parents watching their child struggling to breathe.
Maternal RSV Vaccine Prevents Infection in Infants, Pfizer Announces
Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.
Adult RSV Vaxx Gets EMA Nod: Can USA be Far Behind?
The GSK RSV vaccine candidate has received favorable international regulatory attention which may be an auspicious sign for the US.
Daily Dose: Recombinant Zoster Vaccine Provides 10 Years of Protection
Daily Dose: High-dose Flu Vaccine Consistently More Effective vs Standard-dose
Recombinant Zoster Vaccine Protection Durable at 10 Years, New Study Finds
Efficacy of the RZV vaccine against herpes zoster infection remained >80% in a long-term follow-up study representing 10 years since initial immunization.
COVID-19 Vaccine Status Update: Adults, Bivalent Boosters, Kids, & Teens
The overall US COVID-19 vaccination picture has both bright spots and dark areas. Get a quick look at details from the most recent KFF Vaccine Monitor survey.
High-dose Influenza Vaccine Consistently More Effective vs Standard-dose in Older Adults: Meta-analysis
The high-dose influenza vaccines provided greater relative vaccine effectiveness/efficacy vs standard dose in a cohort of more than 45 million.
Primary Care is the Likely "Home" for Long COVID Care: A Conversation with AAFP Board Chair Sterling Ransone, Jr, MD
AAFP Board Chair Ransone points to recent data that show two-thirds of long COVID patients are already treated in primary care settings.
We Can't Predict a COVID-19 Surge, But We Can Prepare Patients for It: AAFP Board Chair Dr Sterling Ransone, Jr
It is clear that COVID-19 comes in waves, but it's too soon in the life of the virus to predict patterns, Ransone says. Strategy? Get shots in arms.
Will This be the Year of the Twindemic? AAFP Board Chair Ransone Thinks Out Loud with Patient Care
About half of American adults plan not to get a flu shot this year; everyone is tired of COVID talk and prevention; but flu is brewing in the southern hemisphere, Ransone says.
The Daily Dose: Adult RSV Vaccine
Your daily dose of clinical news from Patient Care Online.
COVID-19 Vaccines, Boosters, Prior Infection Significantly Reduce Risks, but Immunity Wanes
A large cohort study confirms the observed efficacy of initial and follow-up COVID-19 vaccination and prior infection against infection, hospitalization, and death.
Are the Southern Hemisphere's High Influenza Rates a Warning for the North This Year?
Influenza rates were higher in Australia during the April-October season this year than they have been in 5 years. Should we be preparing now?
Persistent COVID-19 Vaccine Myths Hamper Immunization for Children
Refractory adult misbeliefs about vaccine safety have increased reluctance to vaccinate US children aged 5-11 years, according to an Annenberg Public Policy center survey.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 23, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 21, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 20, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 19, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 16, 2022